Introduction {#sec1_1}
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Cerebral amyloid angiopathy (CAA) is characterized by the deposition of beta amyloid proteins within the cortical and leptomeningeal vessels. It is a common pathological finding in elderly patients, regardless of concomitant cognitive impairment, and 10--40% of elderly brains have pathological evidence of amyloid deposition \[[@B1]\]. The most frequent presentation of CAA in older patients is intracranial hemorrhage, usually recurrent, sparing regions affected by hypertensive hemorrhage and mainly affecting the cerebral or cerebellar cortex and the cortico-subcortical regions (reflecting locations of amyloid deposition) \[[@B2], [@B3]\]. One of the landmarks in CAA history was the development of the Boston criteria by Greenberg and collaborators in 1996. These criteria were created to improve the diagnostic accuracy of CAA, to provide an easier method for clinical decision-making, and to facilitate a diagnosis during lifetime (without the need for postmortem pathological evaluation) by allowing for probable and possible diagnosis \[[@B2]\]. These criteria reflect the main defining characteristics of CAA (age \>55 years, presentation with multiple parenchymal hematomas and typical pathological findings), but they also accommodate the classical imaging findings of cerebral chronic microbleeds, which represent asymptomatic, small, spontaneous bleedings caused by CAA \[[@B2]\].

Recently, superficial siderosis and cortical subarachnoid hemorrhage (cSAH) in patients with transient focal neurological symptoms (TFNS), the so-called amyloid spells have been related to the phenotype of CAA, and several studies suggest that these findings might predict intracerebral hemorrhages caused by CAA in the long run \[[@B4], [@B5], [@B6]\]. We report a patient who suffered a massive intracerebral hemorrhage 48 h after presenting to the emergency department with TFNS and cSAH.

Case Report {#sec1_2}
===========

A 71-year-old male with a recent history of recurrent episodes of left arm and face paresthesias was admitted to our department after a first generalized convulsive seizure. His past medical history disclosed hypertension, hypercholesterolemia and peripheral arterial disease, but no known epilepsy, cerebrovascular events or cognitive impairment. His usual medication included bisoprolol, sinvastatin and clopidogrel. On admission, his blood pressure was 180/100 mm Hg. A general examination was unremarkable, and a neurological examination revealed mild left facial palsy and left visual and tactile extinction. A CT of his brain showed right parietal and left frontal sulcal cortical subarachnoid hemorrhages (fig. [1a, b](#F1){ref-type="fig"}). An electroencephalogram showed no evidence of paroxysmal activity. His antithrombotic medication was stopped, and the patient was started on phenytoin (100 mg t.d.s.) and perindopril (5 mg o.d.). Despite his treatment, the patient remained confused and agitated and his blood pressure values ranged from 160--200 (systolic) and 70--97 mm Hg (diastolic). On day 2 of his hospitalization, the patient suffered a cardiac arrest and was resuscitated. Afterwards, global aphasia and right hemiplegia were noted. A brain CT revealed a large left frontoparietal and a circumscribed right parietal parenchymal hemorrhage (PH) (fig. [1c, d](#F1){ref-type="fig"}). His cervical and intracranial CT angiograms were normal. The patient\'s blood pressure was controlled with a low dose of bisoprolol and furosemide, and then, there were no further events. A brain MRI at 3 months revealed disseminated superficial siderosis without any microbleeds on T2\* (fig. [1e, f](#F1){ref-type="fig"}). The patient was discharged at 3 months with a modified Rankin Scale score of 4 but died 1 month later of unknown causes and without any autopsy being performed on him. CAA was the assumed cause of death.

Discussion {#sec1_3}
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Despite usually presenting as a PH, CAA is also a recognized and important cause for spontaneous cSAH \[[@B7], [@B8], [@B9]\]. On the other hand, there have also been several reports of patients without the classical CAA findings where blood susceptibility imaging revealed only a superficial siderosis, presumed to be the result of recurrent asymptomatic cortical bleeds \[[@B7], [@B8], [@B10], [@B11]\], suggesting that cSAH can occur not only as a secondary phenomenon in the context of a deep cerebral hemorrhage but also as a primary event \[[@B11], [@B12]\].

Some interest has been found in patients with atypical TFNS who have positive or negative transient symptoms (hemianesthesia or hemiparesis), the so-called 'amyloid spells' \[[@B4], [@B10], [@B13], [@B14]\]. In these patients, blood susceptibility imaging revealed the presence of superficial siderosis, a finding which has been strongly associated with the CAA pathology \[[@B11]\] and which presumably reflects previous spontaneous cSAH. There is no clear explanation for these TFNS, but it is believed that the presence of superficial siderosis could be the catalyst for an epileptic manifestation or even a migraine aura-like cortical spreading depression (as proposed by some authors) \[[@B13]\]. The finding of superficial siderosis in CAA-proven patients, associated with presentations as TFNS, supports the claim that some patients with CAA do not have the classical clinical picture of PH and cerebral microbleeds on MRI, but they can present with TFNS and have isolated superficial siderosis as an imaging marker \[[@B13], [@B14]\], thus reinforcing the need for a revision of the Boston criteria \[[@B10]\]. However, when patients present with TFNS, CAA is usually disregarded as a possible cause, because most of these patients do not have a cognitive decline, and most of them have other cardiovascular risk factors for transient neurological episodes (ischemic events being the main suspect) \[[@B13]\]. Additionally, most of these patients do not undergo susceptibility-weighted MRI. Although the natural history of these patients is not clearly established, several studies suggest that they are at an increased risk of intracerebral bleeding within the next days/months \[[@B5], [@B6], [@B14], [@B15]\]. Curiously, when these PHs occur, they tend to occur in the same location as a pre-existing superficial siderosis (as it has occurred in our patient) \[[@B5], [@B12]\]. It has been suggested that in these patients, the first evidence of bleeding may occur as a cSAH, which could be seen as a warning sign for future PHs \[[@B5], [@B12]\]. The case reports describing these events show a variable latency period between cSAH and PH (range 7--32 days) \[[@B5], [@B12]\], but clearly, and this case seems to have the shortest latency period, the risk can be present since an initial presentation of cSAH. Avoiding antithrombotics has been emphasized before \[[@B4], [@B14]\], but vigilance and strict blood pressure control should also be considered due to the risk of developing severe PHs. Further studies are needed to understand the natural history of patients with amyloid spells and cSAH, but lowering the risk of future bleeds seems to be of utmost importance.

In summary, CAA patients are at a higher risk of PHs and cSAH. Some of these patients can present with transient focal neurological symptoms and have evidence of superficial siderosis on susceptibility-weighted MRI, which would probably reflect previous spontaneous symptomatic or even asymptomatic cSAH. These patients should be tightly monitored, especially regarding their blood pressure profile and because they are at an increased risk of PHs, which can occur in the hyper-acute phase.
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![**a**, **b** A CT scan performed on admission with 2 circumscribed cortical subarachnoid hemorrhages, a frontal left and a right parietal one. **c**, **d** A CT scan 48 h after admission and after cardiac resuscitation with evidence of PHs, a large left frontoparietal and a circumscribed right parietal one, over the original cSAH location. **e**, **f** A brain MRI performed 3 months after admission, revealing disseminated supratentorial superficial siderosis on the T2 gradient echo sequence.](crn-0007-0039-g01){#F1}
